2022 Q1 Form 10-Q Financial Statement
#000156459022013988 Filed on April 08, 2022
Income Statement
| Concept | 2022 Q1 | 2021 Q1 |
|---|---|---|
| Revenue | $9.621M | $5.011M |
| YoY Change | 92.0% | 74.97% |
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | $9.228M | $6.530M |
| YoY Change | 41.32% | 166.53% |
| % of Gross Profit | ||
| Research & Development | $43.14M | $23.00M |
| YoY Change | 87.53% | 77.4% |
| % of Gross Profit | ||
| Depreciation & Amortization | $991.0K | $640.0K |
| YoY Change | 54.84% | 30.61% |
| % of Gross Profit | ||
| Operating Expenses | $52.37M | $29.53M |
| YoY Change | 77.31% | 91.56% |
| Operating Profit | -$42.74M | -$24.52M |
| YoY Change | 74.31% | 95.35% |
| Interest Expense | $211.0K | $320.0K |
| YoY Change | -34.06% | 88.24% |
| % of Operating Profit | ||
| Other Income/Expense, Net | ||
| YoY Change | ||
| Pretax Income | -$42.53M | -$24.20M |
| YoY Change | 75.73% | 95.51% |
| Income Tax | $0.00 | $71.00K |
| % Of Pretax Income | ||
| Net Earnings | -$42.53M | -$24.28M |
| YoY Change | 75.21% | 95.91% |
| Net Earnings / Revenue | -442.09% | -484.43% |
| Basic Earnings Per Share | -$0.95 | |
| Diluted Earnings Per Share | -$951.7K | -$626.1K |
| COMMON SHARES | ||
| Basic Shares Outstanding | 44.74M | 38.91M |
| Diluted Shares Outstanding | 44.69M shares |
Balance Sheet
| Concept | 2022 Q1 | 2021 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $261.1M | $303.1M |
| YoY Change | -13.86% | 325.7% |
| Cash & Equivalents | $78.78M | $126.4M |
| Short-Term Investments | $183.2M | $176.7M |
| Other Short-Term Assets | $11.20M | $3.700M |
| YoY Change | 202.78% | -32.73% |
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | $8.000M | |
| Other Receivables | $204.0K | |
| Total Short-Term Assets | $280.5M | $310.8M |
| YoY Change | -9.74% | 305.17% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $13.52M | $6.960M |
| YoY Change | 94.28% | 74.0% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | $123.7M | $77.20M |
| YoY Change | 60.21% | 915.79% |
| Other Assets | $4.157M | $1.571M |
| YoY Change | 164.61% | 161.83% |
| Total Long-Term Assets | $157.2M | $85.89M |
| YoY Change | 83.06% | 609.85% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $280.5M | $310.8M |
| Total Long-Term Assets | $157.2M | $85.89M |
| Total Assets | $437.7M | $396.7M |
| YoY Change | 10.35% | 346.69% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $6.014M | $4.388M |
| YoY Change | 37.06% | 108.95% |
| Accrued Expenses | $16.85M | $10.80M |
| YoY Change | 56.01% | 66.15% |
| Deferred Revenue | $43.19M | $32.75M |
| YoY Change | 31.86% | |
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $66.05M | $47.97M |
| YoY Change | 37.68% | 59.91% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | $65.75M | $832.0K |
| YoY Change | 7803.13% | -98.97% |
| Total Long-Term Liabilities | $65.75M | $832.0K |
| YoY Change | 7803.13% | -98.97% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $66.05M | $47.97M |
| Total Long-Term Liabilities | $65.75M | $832.0K |
| Total Liabilities | $131.8M | $126.5M |
| YoY Change | 4.17% | 14.61% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$263.4M | -$128.0M |
| YoY Change | 105.82% | |
| Common Stock | $398.1M | |
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $305.9M | $270.1M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $437.7M | $396.7M |
| YoY Change | 10.35% | 346.69% |
Cashflow Statement
| Concept | 2022 Q1 | 2021 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$42.53M | -$24.28M |
| YoY Change | 75.21% | 95.91% |
| Depreciation, Depletion And Amortization | $991.0K | $640.0K |
| YoY Change | 54.84% | 30.61% |
| Cash From Operating Activities | -$42.60M | $8.053M |
| YoY Change | -629.0% | -80.35% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $3.472M | $843.0K |
| YoY Change | 311.86% | 131.59% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $43.50M | -$1.540M |
| YoY Change | -2924.87% | -91.92% |
| Cash From Investing Activities | $40.03M | -$2.387M |
| YoY Change | -1777.04% | -87.71% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 1.488M | 1.359M |
| YoY Change | 9.49% | 2854.35% |
| NET CHANGE | ||
| Cash From Operating Activities | -42.60M | 8.053M |
| Cash From Investing Activities | 40.03M | -2.387M |
| Cash From Financing Activities | 1.488M | 1.359M |
| Net Change In Cash | -1.111M | 7.025M |
| YoY Change | -115.81% | -67.47% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$42.60M | $8.053M |
| Capital Expenditures | $3.472M | $843.0K |
| Free Cash Flow | -$46.07M | $7.210M |
| YoY Change | -739.0% | -82.24% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2021Q4 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
6000000 | |
| CY2022Q1 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0 | |
| CY2022Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2022Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
15872000 | |
| CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
14005000 | |
| CY2021Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
29533000 | |
| CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-42744000 | |
| CY2021Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-24522000 | |
| CY2022Q1 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
211000 | |
| CY2021Q1 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
318000 | |
| CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-42533000 | |
| CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-24204000 | |
| CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
71000 | |
| CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-42533000 | |
| CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24275000 | |
| CY2022Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.95 | |
| CY2021Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.63 | |
| CY2022Q1 | nrix |
Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
|
11419000 | |
| CY2021Q4 | nrix |
Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
|
14549000 | |
| CY2022Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
5430000 | |
| CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3847000 | |
| CY2022Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
43186000 | |
| CY2022Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
66049000 | |
| CY2022Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
10326000 | |
| CY2022Q1 | us-gaap |
Liabilities
Liabilities
|
131803000 | |
| CY2022Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2022Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
| CY2022Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2022Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2022Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2022Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | |
| CY2022Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
44853448 | |
| CY2022Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
44853448 | |
| CY2022Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
52365000 | |
| CY2022Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
44693812 | |
| CY2021Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
38777258 | |
| CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-42533000 | |
| CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24275000 | |
| CY2022Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-1458000 | |
| CY2021Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-38000 | |
| CY2022Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-43991000 | |
| CY2021Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-24313000 | |
| CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
290269000 | |
| CY2021Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
394000 | |
| CY2021Q1 | nrix |
Adjustments To Additional Paid In Capital Share Based Compensation Vesting Of Early Exercised Stock Options
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
|
40000 | |
| CY2021Q1 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
1043000 | |
| CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2700000 | |
| CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-38000 | |
| CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
342302000 | |
| CY2022Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
424000 | |
| CY2022Q1 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
1064000 | |
| CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
305917000 | |
| CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-42533000 | |
| CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-24275000 | |
| CY2022Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
991000 | |
| CY2021Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
643000 | |
| CY2022Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
6071000 | |
| CY2021Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2700000 | |
| CY2022Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-542000 | |
| CY2021Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-222000 | |
| CY2022Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
1262000 | |
| CY2021Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
742000 | |
| CY2022Q1 | us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
2000000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
-7500000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
135000 | |
| CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1514000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-1335000 | |
| CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-103000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
899000 | |
| CY2022Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-1620000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
16990000 | |
| CY2022Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-408000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-737000 | |
| CY2022Q1 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-3318000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
2169000 | |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-42630000 | |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
8053000 | |
| CY2022Q1 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
15245000 | |
| CY2021Q1 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
47742000 | |
| CY2022Q1 | us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
58748000 | |
| CY2021Q1 | us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
46198000 | |
| CY2022Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
3472000 | |
| CY2021Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
843000 | |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
40031000 | |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2387000 | |
| CY2022Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
424000 | |
| CY2021Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
317000 | |
| CY2022Q1 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
|
1064000 | |
| CY2021Q1 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
|
1043000 | |
| CY2021Q1 | nrix |
Payments For Repurchase Of Unvested Early Exercised Stock Options
PaymentsForRepurchaseOfUnvestedEarlyExercisedStockOptions
|
1000 | |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1488000 | |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1359000 | |
| CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-1111000 | |
| CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
7025000 | |
| CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
80792000 | |
| CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
119526000 | |
| CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
79681000 | |
| CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
126551000 | |
| CY2022Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
2207000 | |
| CY2021Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
668000 | |
| CY2022Q1 | nrix |
Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
|
47000 | |
| CY2021Q1 | nrix |
Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
|
40000 | |
| CY2021Q1 | nrix |
Deferred Offering Costs Included In Accounts Payable And Accrued Liabilities
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities
|
343000 | |
| CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
78780000 | |
| CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
126381000 | |
| CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
|
901000 | |
| CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
|
170000 | |
| CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
79681000 | |
| CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
126551000 | |
| CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-42500000 | |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-42600000 | |
| CY2022Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-263400000 | |
| CY2022Q1 | nrix |
Cash Cash Equivalents And Investments
CashCashEquivalentsAndInvestments
|
385700000 | |
| CY2022Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to the useful lives of long-lived assets, the measurement of stock-based compensation, accruals for research and development activities, income taxes and revenue recognition. The Company bases its estimates on historical experience and on other relevant assumptions that are reasonable under the circumstances. Actual results could materially differ from those estimates. Refer to Note 3 for more information regarding the estimates related to revenue recognition.</p> | |
| CY2022Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash, cash equivalents and investments. The Company’s investments consist of debt securities issued by highly rated corporate entities, the U.S. federal government or state and local governments. The Company’s exposure to any individual corporate entity is limited by policy. Deposits may, at times, exceed federally insured limits. The Company invests its cash equivalents in highly rated money market funds. During the periods presented, the Company has not experienced any losses on its deposits of cash, cash equivalents or investments.</p> | |
| CY2020Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
13343000 | |
| CY2020Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3342000 | |
| CY2020Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
10903000 | |
| CY2020Q4 | nrix |
Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
|
8276000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-737000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
2169000 | |
| CY2022Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
29229000 | |
| CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
26219000 | |
| CY2022Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
15707000 | |
| CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
14879000 | |
| CY2022Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
13522000 | |
| CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
11340000 | |
| CY2022Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1000000.0 | |
| CY2021Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
600000 | |
| CY2022Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
4004000 | |
| CY2021Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
8854000 | |
| CY2022Q1 | nrix |
Accrued Contract Research And Lab Supplies
AccruedContractResearchAndLabSupplies
|
5581000 | |
| CY2021Q4 | nrix |
Accrued Contract Research And Lab Supplies
AccruedContractResearchAndLabSupplies
|
4158000 | |
| CY2022Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
1230000 | |
| CY2021Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
803000 | |
| CY2022Q1 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
53000 | |
| CY2021Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
75000 | |
| CY2022Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
551000 | |
| CY2021Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
659000 | |
| CY2022Q1 | nrix |
Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
|
11419000 | |
| CY2021Q4 | nrix |
Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
|
14549000 | |
| CY2022Q1 | nrix |
Transfers Of Financial Instruments Between Valuation Levels
TransfersOfFinancialInstrumentsBetweenValuationLevels
|
0 | |
| CY2021Q1 | nrix |
Transfers Of Financial Instruments Between Valuation Levels
TransfersOfFinancialInstrumentsBetweenValuationLevels
|
0 | |
| CY2022Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
|
0 | |
| CY2021Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
|
0 | |
| CY2022Q1 | us-gaap |
Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
|
0 | |
| CY2021Q1 | us-gaap |
Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
|
0 | |
| CY2022Q1 | nrix |
Impairment Loss On Investment
ImpairmentLossOnInvestment
|
0 | |
| CY2021 | nrix |
Impairment Loss On Investment
ImpairmentLossOnInvestment
|
0 | |
| CY2015Q2 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P60M | |
| CY2022Q1 | us-gaap |
Lessee Operating Lease Description
LesseeOperatingLeaseDescription
|
In November 2017, the Company entered into an amendment to its original lease agreement that combined the Company’s two leases into a single lease agreement and extended the term of the lease agreement through April 30, 2025. | |
| CY2017Q4 | us-gaap |
Lease Expiration Date1
LeaseExpirationDate1
|
2025-04-30 | |
| CY2022Q1 | us-gaap |
Lessor Operating Lease Option To Extend
LessorOperatingLeaseOptionToExtend
|
The Company has an option to renew this lease for an additional two years which has not been included in the lease term used to calculate the ROU asset and lease liability as it is not reasonably certain that the Company will exercise this option. | |
| CY2022Q1 | us-gaap |
Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
|
P2Y | |
| CY2022Q1 | us-gaap |
Security Deposit
SecurityDeposit
|
91000 | |
| CY2020Q2 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P14M | |
| CY2020Q2 | us-gaap |
Lease Expiration Date1
LeaseExpirationDate1
|
2021-07-31 | |
| CY2021Q3 | nrix |
Area Of Office Space Leased
AreaOfOfficeSpaceLeased
|
19320 | |
| CY2021Q3 | nrix |
Lease Commencement Date
LeaseCommencementDate
|
2021-12-01 | |
| CY2021Q3 | us-gaap |
Lease Expiration Date1
LeaseExpirationDate1
|
2024-06-30 | |
| CY2021Q3 | nrix |
Operating Lease Rent Payable Per Month
OperatingLeaseRentPayablePerMonth
|
100000 | |
| CY2021Q3 | nrix |
Percentage Of Increase Of Annual Rent
PercentageOfIncreaseOfAnnualRent
|
0.03 | |
| CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
3800000 | |
| CY2021Q3 | us-gaap |
Security Deposit
SecurityDeposit
|
100000 | |
| CY2022Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
1400000 | |
| CY2021Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
800000 | |
| CY2022Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
1317000 | |
| CY2021Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
846000 | |
| CY2022Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
3916000 | |
| CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
4110000 | |
| CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
5592000 | |
| CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
5060000 | |
| CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
1738000 | |
| CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
16500000 | |
| CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
744000 | |
| CY2022Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
15756000 | |
| CY2022Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
5430000 | |
| CY2022Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
10326000 | |
| CY2022Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
15756000 | |
| CY2022Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | |
| CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | |
| CY2022Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2022Q1 | us-gaap |
Common Stock Voting Rights
CommonStockVotingRights
|
one | |
| CY2021Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
9476306 | |
| CY2022Q1 | nrix |
Share Based Compensation Arrangement By Share Based Payment Award Options Shares Subject To Repurchase
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesSubjectToRepurchase
|
41522 | |
| CY2022Q1 | nrix |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercise Value Of Shares Subject To Repurchase
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExerciseValueOfSharesSubjectToRepurchase
|
300000 | |
| CY2022Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
75200000 | |
| CY2022Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P3Y | |
| CY2022Q1 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
500000 | |
| CY2021Q1 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
200000 | |
| CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
| CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
71000 | |
| CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-42533000 | |
| CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24275000 | |
| CY2022Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
44693812 | |
| CY2021Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
38777258 | |
| CY2022Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.95 | |
| CY2021Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.63 | |
| CY2022Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
7288315 | |
| CY2021Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5251736 |
